AJ Biologics Sdn Bhd Information

AJ Biologics targets the establishment of a vaccine formulations facility with fill and finish capabilities to manufacture a range of selected vaccines for supply to the local, regional and global markets. The facility will adhere to cGMP and international accreditation standards such as PICs, EMEA and WHO. AJ Biologics will engage “flexible manufacturing facility” technology, equipment and design that can be used to manufacture different biological products within the same facility. The primary goal of AJ Biologics is to become a prominent vaccine player, initially in the Malaysian market, followed by the Asian region and eventually globally. In order to meet this eventual goal, we believe in a progressive approach that slowly expands the business portfolio in a structured and focused manner. Progressively expanding the business portfolio will also mitigate risk and allow the company to gradually build its competencies and expertise.